Vitrakvi 20 mg/ml, Lösung zum Einnehmen
7680672820026
CH-67282
Lösung
Associated product:
VITRAKVI sol 20 mg/ml 2 fl 50 ml
1 / 3
google
Article details
- Package size
- 100
- Selling units
- 100
- Measure
- ml
- Galenic form
- Lösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
larotrectinibum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
larotrectinibi sulfas
|
- | Substance | WIZUS |
|
acidum citricum
|
- | Substance | HNIDK |
|
maltodextrinum
|
- | Substance | HNIDK |
|
triethylis citras
|
- | Substance | HNIDK |
|
aromatica
|
- | Substance | AROMA |
|
alcohol benzylicus
|
- | Substance | HBESI |
|
propylenglycolum
|
- | Substance | HNIDK |
|
hydroxypropylbetadexum
|
174.6 MG | Substance | HBESI |
|
E 211
|
2.0 MG | Substance | HBESI |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
sucralosum
|
- | Substance | HNIDK |
|
aqua purificata
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 2118.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2022
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 67282
- Drug name
- Vitrakvi, Lösung zum Einnehmen
- Galenic form
- LSOR
- ATC Code
- L01EX12
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 28/05/2020
- Authorization expiration date
- 19/02/2029
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- VITRAKVI sol 20 mg/ml 2 fl 50 ml
- Description (DE)
- VITRAKVI Lös 20 mg/ml 2 Fl 50 ml
- Market launch
- 28/05/2020
- Narcotic (BTM)
- No
Other package sizes (1)
VITRAKVI sol 20 mg/ml (#) fl verre 100 ml
None None
GTIN: 7680672820019